On the other spectrum, Mounjaro (Tirzepatide), the dual GLP-1 and GIP receptor agonist, has gained FDA approval for its effectiveness in improving blood sugar control in adults with type 2 diabetes, offering an advantage in the treatment landscape with its dual-action mechanism that also contributes to significant weight loss trials
If your BMI is 27 or higher combined with weight-related conditions like Type 2 diabetes, hypertension, or high cholesterol, you might also be eligible for Wegovy
2014;9:e106037
Regular follow-up appointments are essential for monitoring treatment response, adjusting dosage if needed, and ensuring your dietary approach supports both your immediate wellbeing and long-term health goals
Program costs vary based on the medication prescribed, your insurance coverage, and the level of support included
Can I maintain my normal diet while using AOD-9604